"Global medical device market will reach $397.1bn by 2016" according to new visiongain report

A new report by visiongain, a London-based business information provider, predicts that the global medical device market will be worth $397.1bn by 2016. The market generated $309.0bn in 2011, according to Medical Devices Industry and Market Prospects 2012-2022, published in July 2012.

The medical device industry is an attractive and highly profitable industry. Companies in this industry therefore operate in highly competitive environment and require a high capital expenditure in order to develop innovative products. External factors such as government action, economic stability and regulatory landscape can profoundly influence trends in the medical device industry and therefore determine growth. Despite its being a mature market, the medical device industry is made up of several fast growing sectors which are expected to drive growth in the industry in the next decade.

Rodrigo Gutierrez Gamboa, healthcare industry analyst says: “The medical device industry will experience growth in the next decade, primarily due to a global aging population and an increase in the prevalence of chronic diseases, particularly in emerging markets like China and India. The expected approval of innovative devices in fast growing sectors of the market, such the neurological sector, will also help drive growth in the coming years. However, continued economic weakness in major markets of the industry and the introduction of healthcare reforms, such as the US medical device excise tax, will continue to be the major constraints to further growth in the industry”.

Visiongain’s research suggests that the global medical device market will benefit from extensive research particularly in the cardiology and neurological sectors. This will result in the launch of innovative products for which there is a strong market need and will therefore drive the overall market forward. The increase in wealth in emerging markets like China and India will result in lifestyle changes that are expected to increase the prevalence of chronic diseases in these countries. Furthermore, the fast-expanding middle class in emerging economies will result in a higher proportion of the population being able to afford devices that were previously too expensive. Efforts by organisations, such as the International Medical Device Regulators Forum, to harmonise the approval process for medical devices across major international markets will also help drive the market forward as companies will be further encouraged to expand their operations abroad.

Visiongain predicts this market will grow steadily to 2022. The future of the global medical device market appears promising and has significant potential for growth and investment, with the increasing demand in many therapeutic areas. This new report adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.

For sample pages and further information concerning the Visiongain report Medical Devices Industry and Market Prospects 2012-2022 please visit: http://www.visiongain.com/Report/849/Medical-Devices-Industry-and-Market-Prospects-2012-2022

For an executive summary of this report or to order it today, please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Aviation and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Visiongain
BSG House
226-236 City Road
London EC1V 2QY
United Kingdom

This release was published on openPR.